Haematology Flashcards

1
Q

define haematocrit or PCV

A

percentage of which the cells make up the total volume

40-52%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

define mean cell haemoglobin

A

the amount of haemoglobin in an individual cell

Hb/RCC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

define mean cell volume

A

the size of the cell

PCV/RCC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

define mean cell haemoglobin concentration

A

the concentration of the haemoglobin in the cell

Hb/PCV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

define reticulocyte count

A

a measure of the immature red cells

whether there are young red cells being made and active or increased red cell turnover

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what are the findings in microcytic anaemia?

A

reduced Hb, Hct, RCC, MCH, MCHC
MCV reduced below the normal range
anaemia with small, poorly haemoglobinised red cells
blood film - small, abnormal shape, paler (less Hb), bigger area of central clearing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what is the different between latent iron deficiency and iron deficiency anaemia?

A

latent iron deficiency - iron stores are cleared, but cells are ok
continued iron deficiency - hypo chromic, microcytic red cells, reduction in MCV, MCH and MCHC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what are the findings in macrocytic anaemia?

A

reduced Hb, Hct, RCC
normal MCH and MCHC (looking at the amount of Hb in the individual cell)
MCV increased
blood film - less red cells, larger, extra lobes in the white cells (problem with cell division)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what are the causes and treatment of macrocytic anaemia?

A

vitamin B12 or folic acid deficiency

replacement of deficiency
do not require a blood transfusion unless severely symptomatic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

describe neutrophils

A

2-5 lobed nucleus
Barr body - protrusion from one of the lobes and present in XX
dense nucleus
granules present from promyelocyte stage right through to the mature nucleus
contain myeloperoxidase, phosphatase, acid hydrolases
secondary granules develop from the myelocyte stage and contain collagenase, lactoferrin, lysosome
very fast turner
lifespan of 10 hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what are the functions of neutrophils?

A

fighting infection
chemotaxis
phagocytosis
killing of phagocytosed bacteria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

describe eosinophils

A
bilobed nucleus
bright pink granules
pale blue cytoplasm
larger than neutrophils
remain longer in the circulation than neutrophils
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what are the functions of eosinophils?

A

fight infection
enter inflammatory exudates
play a role in immediate type hypersensitivity reactions and antibody-dependent parasite damage
high count in allergic reactions or parasites

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

describe basophils

A

dark granules
often overlay and obscure the nucleus
larger than neutrophils
move from the circulation into the tissues; mast cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what are the functions of basophils?

A

immediate type hypersensitivity reactions
IgE attachment sites
degranulation and histamine release in allergic responses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

describe monocytes

A
large cells
bilobed nucleus
pale blue cytoplasm
granules in the nucleus
largest white cells
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

what are the functions of monocytes?

A

killing of microorganisms
release of cytokines
rare cells in the circulation; not often seen on routine blood films

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

describe lymphocytes

A

similar size as RBC
very little cytoplasm
activated with various infections; on activation can contain large amounts of cytoplasm, sometimes with granules

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

describe T lymphocytes

A

originate in the thymus
usually parafollicular in the nodes and periarteriolar in the spleen
make up 80% of the lymphocytes in the blood
have membrane receptors for the T-cell receptor antigen
function - T helper cells, part of antibody production

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

describe B lymphocytes

A

originate in the bone marrow
have membrane receptors for immunoglobulin
function - humoral immunty

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

describe immunoglobulins

A

produced by plasma cells and B lymphocytes

part of the defence against foreign organisms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

what is the treatment of infectious mononucleosis (glandular fever)?

A

symptomatic
occasionally require corticosteroids
must not get any ampicillin; may gets rashes with this
recovery will be quite slow

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

describe platelets

A

cellular fragments involved in clotting and bleeding

produced in the bone marrow from the megakaryocyte (contained in the cytoplasm)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

what is the cause of low large platelets?

A

immune thrombocytopenic purpura

some reason that they are producing an antibody that is destroying their platelets

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

describe the pathophysiology and treatment of immune thrombocytopenic purpura

A

platelet turnover increased
large immature platelets released into the circulation

steroids
immunoglobulins
anti-D
splenectomy (Howell-Jolly bodies)
do not benefit greatly from platelet transfusion
not useful unless they have life-threatening bleeding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

what is the cause of increased platelets?

A

essential thrombocythaemia
infection
reactive cause

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

what is the treatment of essential thrombocythaemia?

A

aspirin whenever the platelet count >1000
decreased the tendency to thromboembolic phenomenon
may need cytoreduction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

describe platelet activation

A

glycoprotein IIb sticks to the injured vessel wall
this slows the platelet down to go through secondary activation; glycoprotein IIb/IIIa is upregulated/further expressed
this causes more platelets to stick together
releases 5-HT, ADP, thromboxane, fibrinogen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

what are the uses of glycoprotein IIb/IIIa inhibitors?

A

angiography of acute MI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

what drugs inhibit the substances released by platelets (causing bruising)?

A

SSRIs
aspirin
NSAIDs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

what is the trigger for the clotting cascade?

A

tissue factor exposure at the vessel wall site which will activate clotting factor VII
triggers prothrombin cleavage to thrombin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

what is the result of the clotting cascade?

A

fibrin activation with factor XIII

makes a firm clot

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

which factor is not essential in the clotting cascade?

A

factor XII

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

what does warfarin suppress?

A

protein C and S (vitamin K-dependent anticoagulants)

factor II, VII, IX, X

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

what is the role of antithrombin?

A

switches off the activation of factor XI, X, XI§

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

what does a normal coagulation screen indicate?

A

normal patient
von Willebrand’s disease (AD)
factor XIII deficiency
platelet disorders

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

what are the signs of bleeding disorders?

A
mucocutaneous (epistaxis >30mins)
unexplained menorrhagia >80ml per cycle
post-dental extraction
post-childbirth
petechiae, purpura, soft tissue haematoma
loss of function
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

what are the causes of a deranged coagulation screen?

A

paracetamol overdose
liver disease
stress (shortened APTT, high factor VIII level)
tourniquet placed on the arm for a long time
traumatic venepuncture
taken from an in-dwelling line (often locked with heparin)
transport delay
heating of the bottle
high Hct (citrate acts as a diluting for clotting factors)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

what are the causes of prolonged PT?

A
extrinsic pathway;
primary factor VII problem
early warfarinisation
congenital factor VII deficiency
early sepsis
early vitamin K deficiency
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

what are the causes of a prolonged PT and APTT?

A

common pathway;
vitamin K deficiency (factor II, VII, IX, X)
oral warfarin therapy
oral dabigatran therapy
DIC; septicaemia, meningitis, malignancy (directly activate factor X)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

what are the causes of prolonged APTT?

A
intrinsic pathway;
DIC
liver disease
massive transfusion
unfractionated heparin therapy monitoring
heparin contamination in line locks
oral warfarin therapy
lupus anticoagulant (antiphospholipid syndrome)
factor VII, IX, XI, XII deficiency
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

describe an APTT correction study

A

undertaken whenever the APTT is abnormal
if it corrects when normal plasma is added; clotting factor deficiency (ES liver disease)
if it does not correct; lupus anticoagulant present

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

describe D-dimer

A

breakdown product of clot
present in any form of inflammation
positive in >3/4s of those >60 with good health
positive; suspected case of DIC
used to see if thrombolytic therapy is working

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

how is D-dimer used in suspected venous thromboembolism?

A

negative predictive value

used with the wells score

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

what is the cause of bleeding with normal PT, APTT, fibrinogen?

A

von willebrand’s disease
factor VIII deficiency
platelet dysfunction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

what is the cause of bleeding with prolonged PT only?

A

early warfarin deficiency

factor VI deficiency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

what is the cause of bleeding with prolonged APTT only?

A

factor VIII, IX, XI XII deficiency
lupus anticoagulant
unfractionated heparin present (clinically or due to line contamination)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
48
Q

what is the cause of bleeding with PT and APTT prolonged?

A

oral warfarin therapy
vitamin K deficiency
oral direct thrombin inhibitor dabigatran

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
49
Q

what is the cause of bleeding with PT and APTT prolonged and fibrinogen reduced?

A

hyperfibrinolysis
severe end stage liver disease
DIC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
50
Q

what is the problem with testing levels of protein C, S and antithrombin at the time the clot is diagnosed?

A

they are frequently reduced as it is the body’s response that these anticoagulants will be dissolving the clot

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
51
Q

what are the causes of a reduced antithrombin level?

A

low molecular weight heparin

unfractionated heparin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
52
Q

what is the cause of a suppressed protein C and S level?

A

warfarin therapy

53
Q

describe factor V Leiden

A

activated protein C resistance
more likely to clot
poorly penetrant; having the mutation does not guarantee that you will suffer from a VT
increased risk in pregnancy, lower limb in immobilised plaster cast

54
Q

describe the prothrombin gene mutation

A

G20210A

very weak increase in the risk of a deep vein thrombosis but not in a PE

55
Q

describe antiphospholipid syndrome

A

autoimmune
hyper coagulable state
promotion of blood clots in the arteries and veins
positive lupus anticoagulant

56
Q

what blood disorders can be caused by anti-D antibodies?

A

haemolytic disease of the new-born

transfusion reactions

57
Q

define agglutination

A

the aggregation of antigens and antibodies

haemagglutination in red cells

58
Q

describe the expression of A antigens

A

A1 - vey strong expression

A2 - very weak expression

59
Q

describe reverse grouping

A

testing patient plasma for anti-A and anti-B
patient plasma is added to suspensions of group A1 and B red cells
haemagglutination; B + anti-B; blood group A

60
Q

describe antibody screening

A

used to screen patient plasma for clinically significant red cell antibodies other than anti-A and anti-B
haemagglutination; red cell antibody present

61
Q

describe forward grouping

A

testing for the presence of A and B antigens on patient red cells
suspension of patient red cells is prepared, monoclonal antiserum and anti-A or anti-B is added
haemagglutination; anti-A + A antigens; blood group A

62
Q

describe an antibody identification test

A

performed if the antibody screening test is positive

if a red cell antibody is identified, then red cells lacking that antigen must be selected for crossmatch

63
Q

describe the electronic crossmatch

A

faster response to requests
less wastage
reduction in laboratory workload
cannot be used for patients with clinically significant red cell alloantibodies

64
Q

describe serological crossmatch

A

the addition of patient plasma to a suspension of donor red cells

65
Q

what feature are essential for an intact and functioning haemoglobin molecule?

A

2 properly formed alpha and beta globin chains each
iron
haem molecule

66
Q

describe the beta globin genes

A

on chromosome 11

4 genes; epsilon, gamma, delta, beta

67
Q

describe the alpha globin genes

A

on chromosome 16

4 genes; 2 alpha, 2 zeta

68
Q

name the haemoglobin that occur in humans

A
HbA; alpha 2 beta 2
HbA2; alpha 2 delta 2
HbF; foetal, alpha 2 gamma 2
Hb portland; embryo, zeta 2 gamma 2
Hb Gower 1; embryo, zeta 2 epsilon 2
Hb Gower 2; embryo, alpha 2 epsilon 2
69
Q

define haemoglobinopathies

A

serious anaemias caused by the inheritance from both parents of changes in the structure/synthesis of the individual globin chains of haemoglobin
usually inherited in AR
parents are usually healthy carriers

70
Q

describe the pathology of haemoglobin E, C, D

A

single point mutations in an individual globin gene

71
Q

why have haemoglobinopathies become so widespread?

A

protection from malaria

72
Q

describe alpha thalassaemia carrier state

A

genetic defect in the production of one or more of the alpha-globin genes
symptomless carrier state
common in Southeast Asia or eastern mediterranean

73
Q

describe the disease of alpha thalassaemia

A

severe disease; haemoglobin bart’s, hydros foetalis
no production of alpha-globing correctly
death of the baby in utero or soon after birth; severe anaemia
serious clinical problems for the mother during pregnancy

74
Q

describe the pathology of alpha thalassaemia

A
Hb bart's in foetus; 4 gamma globin genes
Hb H in adults; 4 beta globin genes
high oxygen affinity
severe tissue hypoxia
inclusion bodies
membrane damage
red cells are broken down by haemolysis
compensatory hypersplenism; unsuccessful
severely anaemia foetus/baby
75
Q

what are the symptoms and signs of a pregnancy woman with alpha thalassaemia

A
mild anaemia
low Hb
low MCV
normal WCC, PLT, MCH, MCHC
blood film; mild, minor changes in red cells
76
Q

describe the inheritance of alpha thalassaemia

A

3/4; compatible with life, some normal adult haemoglobin made, will grow to adulthood, quite anaemic
4/4; born with severe anaemia, probably die shortly after birth, alpha thalassaemia major

77
Q

what are the signs and symptoms of alpha thalassaemia major?

A

blood film;
severely abnormal red cells; large, pale, containing very little Hb
nucleated RBCs; increased red cell turnover, normally not seen in a neonate

splenomegaly
severely anaemic
in heart failure

78
Q

describe the carrier state of beta thalassaemia

A

defect in the beta-globing gene
failure of production of the beta-globing protein
symptomless carrier state
common in the mediterranean, Middle East, Indian subcontinent, south east Asia, pacific island populations

79
Q

what are the symptoms and signs of beta thalassaemia major?

A
low Hb
normal WCC, PLT
anaemic from birth
film; poorly haemoglobinised red cells, with many abnormalities, nucleated RBCs
small for their age
prominent head
soft feeling to the head; bone marrow cavity is expanded to make increased amount of blood to compensate for haemolysis and failure of normal Hb production
hepatic splenomegaly
80
Q

why is beta thalassaemia major compatible with life?

A

first 6 months of life there is HbS; foetal Hb, containing 2 alpha and 2 gamma chains
only as the beta globin chains take over as the normal adult Hb they become increasingly anaemic
failure of production of adult Hb

81
Q

what is the treatment of beta thalassaemia major?

A

transfusions
try and dampen down their own haematopoiesis as much as possible
entirely dependent on a transfusion regime

82
Q

what are the symptoms and signs, if any, of beta thalassaemia carrier state?

A

mildly anaemic
microcytic picture
normal MCHC
blood film; quite a lot of red cell abnormalities, variation of size and shape, pale, poorly haemoglobinised red cells

83
Q

describe the thalassaemia trait indices

A
similar in both alpha and beta globin defects
low Hb
microcytosis
normal/raised RCC
low MCH
normal MCHC
84
Q

what are the symptoms, signs and maintenance of thalassaemia trait?

A

microcytic anaemia due to globin gene defect
normal RCC and MCHC
require ferritin measurement to prove if they are iron deficient
require genetic screening
have some protection against malaria

85
Q

define sickle cell disease

A

caused by a single mutation in the beta globin gene at position 6, leading to an amino acid change of glutamic acid to valine

86
Q

describe sickle cell carrier state

A

common in tropical Africa, the Middle East, India, caribbean islands, south america
AR inheritance

87
Q

describe the signs and symptoms of sickle cell disease

A

low Hb
normal WCC and RCC
blood film; red narrowed (sickle) cell

88
Q

what are the causes of cell shape changes in sickle cell disease?

A

lack of oxygen
are later destroyed or haemolysed
destruction; leads to many of the problems in the disorder
irreversible change

89
Q

what are the clinical features of sickle cell anaemia/haemolytic anaemias?

A

chronic red cell breakdown; jaundice, yellow sclera
splenomegaly
bony lesions; pain, crises
severe pain with trauma, infection, cold exposure, dehydration
chronic ill health
repeated cerebral infarctions; strokes, major long-term morbidity

90
Q

what is the management of sickle cell anaemia/haemolytic anaemias?

A
treatment the complications and symptoms
transfusions
screening; minus Northern European
neonates; heel prick test
antenatal; ideally pre-conception, anybody at risk of HbS, alpha or beta thalassaemia
91
Q

what does morphology refer to?

A

appearance of the cells

in blood, bone marrow, lymph node or other tissues

92
Q

describe the morphology of acute promyelocytic leukaemia

A

larger number of large cells
abundant cytoplasm
nucleus almost obscured by the presence of large granules within the cytoplasm

93
Q

describe the morphology of acute lymphoblastic leukaemia B-lineage

A

pleomorphic population of large cells
convoluted nuclei
prominent nucleoli
clearly blast cells, but cannot be certain of the lineage; myeloid, B or T lymphoid

94
Q

describe the morphology of hairy cell/chronic B lymphocytic leukaemia

A

oval/round nucleus
cytoplasm with abundant villous projections
similar cells are found in other disorders

95
Q

describe the immune-phenotype of a cell population

A

the pattern of antigen expression
on the cell surface and intracellularly
assessed by flow cytometry

96
Q

describe flow cytometry

A

cells in suspension pass in single file through a laser beam
the cell momentarily breaks the beam and scatters the light
the light is collected by a combination of filters, mirrors and detectors and the data is recorded

97
Q

what cell suspensions are measured by flow cytometry?

A

blood
bone marrow
CSF
pleural fluid

98
Q

how are cell population identified in flow cytometry?

A

physical characteristics, scatter

antigen expression, fluorescence

99
Q

how is antigen expression assessed in flow cytometry?

A

cells are incubated with an antibody linked to a fluorochrome
the number of cells and intensity of antigen expression depends on the strength of the light emitted

100
Q

what does an antibody panel assess?

A

cell lineage; myeloid or lymphoid origin, B, T or NK cell

stage of differentiation; degree of maturity

101
Q

describe CD45

A

the common leukocyte antigen

expressed on all white blood cells

102
Q

what is the pattern of antigen expression on AML?

A
CD34
CD33
CD13
myeloperoxidase
HLA-DR
CD117
103
Q

what is the immune-phenotype of acute lymphoblastic leukaemia?

A

weeks CD45 expression
lower side scatter
positive for TDT, CD10, CD19, HLA-DR

104
Q

describe cytogenetics

A

refers to the chromosomes of the cell population
cell division is arrested at metaphase
giemsa staining produces specific bounding patterns along the chromatids
examined under a high power microscope
identify individual chromosomes and produce a karyotype

105
Q

describe the abnormalities of a karyotype in haematological malignancies

A

numerical abnormalities; extra or missing copies
structural abnormalities; translocations, inversions, deletions
diagnostic; CML, APL
prognostic; acute leukaemias

106
Q

describe FISH

A

a single standard DNA probe anneal to its complementary sequence in the target genome
detects and localises specific DNA sequences

107
Q

what are the advantages of FISH?

A

can visualise abnormalities in non-dividing cells; useful in CLL with low mitotic index
can be performed on directly-prepared samples rather than requiring cell culture
larger number of cells can be analysed
can detect cryptic rearrangements
can be performed on tissue sections; bone marrow trephine biopsies

108
Q

describe FISH probes

A

chromosome paints; hybridise to metaphases to visualise different chromosomes at the same time, can determine the origin of structural abnormalities
locus-specific probes; target genes of interest, identify rearrangement, deletions or gains in metaphase and interphase

109
Q

describe the diagnosis of acute promyelocytic leukaemia

A

must be confirmed by cytogenetic analysis
defining chromosomal abnormality; translocation between long arm of chr 15 and 17; PML-RARA fusion gene
cryptic abnormalities can result in a PML-RARA fusion gene; detected by a FISH probe for RARA gene on chr 17

110
Q

describe the diagnosis of AML

A

abnormalities of chr 5, 11, 15, 17 and a complete loss of chr 8
specific loss of the long arm of chr 5; poor prognosis

111
Q

define PCR

A

a method by which DNA is amplified to produce thousands of copies of the same sequence

112
Q

define taq polymerase

A

the thermostable/heat stable enzyme which extends the primers by the sequential addition of nucleotides to synthesise a complementary DNA strand from the original template

113
Q

define deoxynucleoside triphosphates/dNTPS

A

the building blocks used by Taq polymerase to synthesis the new DNA strand

114
Q

describe the process of PCR

A

denaturation at 95 degrees; separation of the double strands of DNA
annealing; cooling of the reaction
primers bind to their complementary sequences
higher temperature; taq polymerase carries out the extension phase
dNTPs are added to synthesise the new strand

115
Q

describe gel electrophoresis

A

analysing PCR product
migration through an agarose gel
separation of the reaction products by their size alongside a molecular weight marker
visualised using ethidium bromide (EB) staining and UV light

116
Q

describe reverse transcriptase PCR

A

converts messenger RNA to complementary DNA (or cDNA)

117
Q

describe allele-specific PCR

A

uses primers which include a known mutation

detect the JAK2 V617F mutation; myeloproliferative neoplasm

118
Q

what are the clinical applications of PCR?

A
BCR-ABL fusion gene detection; CLL
philadelphia positive variant; ALL
JAK2 V617F and MPL mutations; myeloproliferative neoplasms
FLT3 and NPM mutation; AML
PML-RARA; acute promyelocytic leukaemia
119
Q

describe the morphological features of CML

A
blood;
neutrophil leukocytosis
granulocyte prescursors at all stages of maturation
basophilia prominent
degree of eosinophilia
blasts present, not increased
high platelet count
bone marrow aspirate;
markedly hypercellular
granulocytic hyperplasia
normal differentiation
basophils and eosinophils prominent
blasts present, not increased
megakaryocytes; smaller, reduced nuclear lobulation
120
Q

describe the cytogenetic findings of CML

A

reciprocal translocation between the long arms of chr 9 and 22
abnormal chr 22; philadelphia chromosome
BCR-ABL1 fusion oncogene
abnormal protein function directly produces the clinical and haematological phenotype of CML
loss of Y chromosome

121
Q

what is the management of CML?

A

TKI; imatinib 400mg daily
monitor haematological response by blood counts or cytogenetic analysis
BCR-ABL1 transcript level; measured by real-time PCR
complete molecular response; BCR-ABL1 fusion gene is no longer detectable
rise in transcript levels; therapy failure, development of mutations within BCR-ABL fusion gene

122
Q

describe the BCR-ABL dual fusion FISH probe

A

normal red signal, normal green signal and 2 abnormal fusion signals (yellow)

123
Q

describe the symptoms and signs of CLL

A
weight loss
sweats
malaise
widespread lymphadenopathy
hepatosplenomegaly
raised WCC
mild anaemia
thrombocytopenia
124
Q

describe the symptoms and signs of CML

A

fatigue
left hypochondriac discomfort; splenomegaly
raised WCC
moderate thrombocytosis

125
Q

describe the morphology of CLL

A

blood;
small cells
very scant cytoplasm
condensed nuclear chromatin

bone marrow trephine;
nodular infiltrate of small cells in the peripheral blood

126
Q

describe the flow cytometry of CLL

A

positive for CD19, 20, 5
negative for CD10
weak expression of surface light chain

127
Q

what features indicate advanced CLL?

A
anaemia
thrombocytopenia
lymphocyte doubling time
CD38 expression on lymphocyte surface
17p deletion presence; more aggressive and failure to respond to purine analogue therapy
128
Q

what is the treatment of CLL?

A

absence of 17p deletion; rituximab, fludarabine, cyclophosphamide